Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results